The Duke Adult Bone Marrow and Stem Cell Transplantation (ABMT) Program is internationally recognized for its novel approaches to treating leukemia, lymphoma, myeloma, and other solid tumors through bone marrow and peripheral blood progenitors transplantation.

We also treat novel indications such as autoimmune disease and hemoglobinopathies.

The ABMT’s interdisciplinary team, led by director Nelson Chao, MD, is committed to providing the best care to each individual patient.